Clinical Trials Logo

GD2 Positive Glioma clinical trials

View clinical trials related to GD2 Positive Glioma.

Filter by:
  • None
  • Page 1

NCT ID: NCT03252171 Withdrawn - Clinical trials for CAR-T Cell Immunotherapy

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

Start date: October 15, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with GD2 positive glioma patients.